Development of resistance to hydroxyurea during treatment of human myelogenous leukemia K562 cells with alpha-difluoromethylornithine as a result of coamplification of genes for ornithine decarboxylase and ribonucleotide reductase R2 subunit. (Q41517550)
Jump to navigation
Jump to search
scientific article published on November 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of resistance to hydroxyurea during treatment of human myelogenous leukemia K562 cells with alpha-difluoromethylornithine as a result of coamplification of genes for ornithine decarboxylase and ribonucleotide reductase R2 subunit. |
scientific article published on November 1993 |
Statements
Development of resistance to hydroxyurea during treatment of human myelogenous leukemia K562 cells with alpha-difluoromethylornithine as a result of coamplification of genes for ornithine decarboxylase and ribonucleotide reductase R2 subunit (English)
Ask A
Persson L
Rehnholm A
Frostesjö L
Holm I
1 November 1993